Competitive N-[3-Chloro-4-(3-Fluorobenzyloxy)-Phenyl]-6-Iodoquinazolin-4-Amine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to
sales7@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: sales7@bouling-chem.com
As a leading N-[3-Chloro-4-(3-Fluorobenzyloxy)-Phenyl]-6-Iodoquinazolin-4-Amine supplier, we deliver high-quality products across diverse grades to meet evolving needs, empowering global customers with safe, efficient, and compliant chemical solutions.
What is the chemical structure of N- [3-chloro-4- (3-fluorobenzyloxy) -phenyl] -6-iodoquinazolin-4-amine
This is the chemical structure analysis of N- [3-chloro-4- (3-fluorobenzyloxy) phenyl] -6-iodoquinazoline-4-amine. Its chemical structure is composed of several parts:
1. Quinazoline core structure: This is the basic framework of this compound. Quinazoline contains a benzene ring fused with a pyrimidine ring to form a bilicyclic structure. In this compound, the quinazoline ring is connected to an amine group (-NH ²) at the 4th position, and an iodine atom (-I) is connected at the 6th position.
2. Phenyl ring substituent: 3-chloro-4- (3-fluorobenzoxy) phenyl is connected to the nitrogen atom of the quinazoline ring. In this part, the benzene ring has a chlorine atom (-Cl) substituted at position 3, a benzyl group is connected through an oxygen atom at position 4, and a fluorine atom (-F) substituted at position 3 of the benzene ring.
3. Specific connection method: The nitrogen atom is connected to the benzene ring of 3-chloro-4- (3-fluorobenzyloxy) phenyl group to form a complete N - [3-chloro-4- (3-fluorobenzyloxy) phenyl] -6-iodoquinazoline-4-amine chemical structure. The spatial arrangement and interaction of different atoms and groups in this structure have important effects on the physical, chemical and biological activities of the compound.
What is the main use of N- [3-chloro-4- (3-fluorobenzyloxy) -phenyl] -6-iodoquinazolin-4-amine
N- [3-chloro-4- (3-fluorobenzoxy) -phenyl] -6-iodoquinazoline-4-amine, which is one of the organic compounds. Its main use has attracted much attention in the field of pharmaceutical chemistry research.
In many medical studies, the structure of such compounds often has unique activities, or can be used as lead compounds for the development of new drugs. Its structure contains halogen atoms such as chlorine, fluorine, iodine, and quinazoline, benzoxy and other groups. Each group works synergistically, or can exhibit biological activities such as antibacterial, antiviral, and antitumor.
Taking the field of anti-tumor as an example, such compounds may exert anti-cancer effects through specific mechanisms, such as interfering with the signaling pathways of tumor cells and inhibiting the activities of key enzymes required for tumor cell proliferation. In terms of antibacterial and antiviral, it may also be combined with specific targets of pathogens to hinder the growth and reproduction of pathogens.
Furthermore, in the structural optimization research of pharmaceutical chemistry, this compound can be used as a basis. By modifying its substituents, the relationship between different structures and biological activities can be explored, and then innovative drugs with better efficacy and less side effects can be developed. Therefore, in the early stage of new drug development, it is a promising research object, and its contribution to the field of medicine may be unlimited.
What are the synthesis methods of N- [3-chloro-4- (3-fluorobenzyloxy) -phenyl] -6-iodoquinazolin-4-amine
There are several ways to prepare N- [3-chloro-4- (3-fluorobenzyloxy) phenyl] -6-iodoquinazoline-4-amine. First, the quinazoline skeleton can be constructed from the starting material through a multi-step reaction, and then a specific substituent can be introduced. For example, a suitable aniline derivative is first condensed with the corresponding halobenzoic acid derivative under appropriate conditions to form an amide intermediate. This amide is cyclized under the action of a dehydrating agent to form a quinazoline parent nucleus.
Then, for the 3-chloro-4- (3-fluorobenzoxy) phenyl substituent in the target molecule, a reagent containing chlorine and fluorobenzoxy can be selected to undergo a nucleophilic substitution reaction with the quinazoline parent nucleus under basic conditions to introduce this key fragment. As for the 6-iodine substituent, an iodizing reagent can be used. In a suitable reaction system, iodine atoms are introduced into the 6-position of the quinazoline ring through a halogenation reaction.
Second, quinazoline can also be used as a starting material to undergo a halogenation reaction first, and iodine atoms are selectively introduced at the 6-position. Afterwards, the 3-chloro-4- (3-fluorobenzyloxy) phenyl substituent is attached to the nitrogen atom of quinazoline through nucleophilic substitution reaction. During the nucleophilic substitution reaction, a suitable base should be selected to promote the reaction, and the reaction temperature and time should be controlled to ensure the high efficiency and selectivity of the reaction.
During the preparation process, attention should be paid to the control of the reaction conditions at each step, such as the reaction temperature, solvent selection, and the proportion of reactants, which all have an important impact on the reaction yield and product purity. In addition, post-treatment and product purification steps are also indispensable. Column chromatography, recrystallization and other methods are commonly used to obtain high-purity target products N- [3-chloro-4- (3-fluorobenzyloxy) phenyl] -6 -ioquinazoline-4 -amine.
What is the safety of N- [3-chloro-4- (3-fluorobenzyloxy) -phenyl] -6-iodoquinazolin-4-amine
N- [3-chloro-4- (3-fluorobenzyloxy) phenyl] -6-iodoquinazoline-4-amine is an organic compound. To discuss its safety, it is necessary to observe it from multiple aspects.
First, the chemical structure of this compound contains halogen elements such as chlorine, fluorine, iodine, and quinazoline, benzyloxy and other structures. The introduction of halogen elements may make the compound have certain chemical activity and toxicity potential. When it interacts with molecules in vivo, it may interfere with the biochemical reaction process by the special electronic effect of halogen atoms.
Second Toxicology. Without detailed experimental data, it is difficult to determine its acute toxicity, such as oral, transdermal or inhaled half lethal dose. However, compounds with similar structures, containing halogenated aromatic structures, often damage biological cells, or cause toxicity to liver, kidney and other organs. Long-term exposure to this compound may pose potential chronic toxicity, such as carcinogenesis, teratogenicity, mutagenicity and other risks. Covered because of its structure can react with biological macromolecules such as DNA, leading to changes in genetic material.
Environmental safety should not be ignored. If this compound is released into the environment, its structure is complex, or it is difficult to be rapidly degraded by microorganisms, resulting in environmental residues. Its ecotoxicity to aquatic organisms and terrestrial organisms needs to be studied in detail. Or enriched through the food chain, endangering the balance of ecosystems and human health.
The safety of N- [3-chloro-4- (3-fluorobenzyloxy) phenyl] -6-iodoquinazoline-4-amine is unknown, and rigorous toxicological experiments and Environmental Impact Assessments are required to determine the degree of biological and environmental hazards to determine safe use and disposal.
What is the market prospect of N- [3-chloro-4- (3-fluorobenzyloxy) -phenyl] -6-iodoquinazolin-4-amine?
There is a product named N- [3-chloro-4- (3-fluorobenzyloxy) -phenyl] -6-iodoquinazoline-4-amine. Looking at its market prospects, there are many considerations.
This compound has potential opportunities in the field of pharmaceutical research and development. Today, the search for new specific drugs has not stopped, and many pharmaceutical companies and scientific research institutions are making great efforts to explore molecules with unique pharmacological activities. If this compound is studied in depth, it can demonstrate high-efficiency affinity and regulation of specific disease targets, such as anti-tumor, anti-virus and other key disease directions, it will surely attract market attention.
Furthermore, in the field of pesticides, it may also have potential. With the increasing demand for high-efficiency, low-toxicity and environmentally friendly pesticides in agriculture, if this substance can demonstrate excellent control efficiency against common pests and diseases, and meet the stringent standards of environmental protection, it will definitely be able to get a share of the pesticide market.
However, the road to the market is not all smooth. The complexity of the synthesis process is the first problem. If the preparation process is cumbersome and costly, even if its activity is excellent, large-scale industrial production and marketing activities will be difficult.
In addition, regulatory supervision is also a factor that cannot be ignored. Pharmaceuticals and pesticides are related to people's livelihood and ecological security, and countries have strict regulations. If this compound wants to enter the market, it must undergo many rigorous tests and approvals to prove its safety and effectiveness.
To sum up, the market prospect of N- [3-chloro-4- (3-fluorobenzoxy) -phenyl] -6-iodoquinazoline-4-amine, although it contains hope, is also full of thorns. It must be refined by scientific research, production, regulations, etc., to know its final market trend.